The results of CD31 staining illustrated that vaccine, PD-1 antibody and combination therapy treatment reduced angiogenesis in Lynch syndrome mouse model, and combination therapy exhibited the best effect (Figures 5A,B). Here, PECAM1 is linked to Lynch syndrome.